BioSpace News Archive

Business

Epigenomics AG terminates collaboration with Chinese licensing partner and announces anticipated revenue growth in 2019 outlook

Epigenomics AG today has decided to terminate its collaboration with its Chinese partner BioChain for the licensing of the Septin9 marker and the exclusive distribution rights in China for Epi proColon

March 7, 2019
·
2 min read
Drug Development

Alex Trebek’s Pancreatic Cancer Diagnoses Focuses Attention on the Tough-to-Treat Disease

Alex Trebek, 78, host of TV game show “Jeopardy” announced yesterday that he had been diagnosed with stage 4 pancreatic cancer.

March 7, 2019
·
4 min read
·
Mark Terry
Deals

Oncternal and GTx to Merge, Form New Company Based in San Diego

No employees of GTx are expected to remain with the new company once the merger is complete. Oncternal will begin to trade on the Nasdaq under the ticker symbol ONCT.

March 7, 2019
·
2 min read
·
Alex Keown
Drug Development

Atara Biotherapeutics’ Cancer Drug Might—Might!—Have Applications for MS

This year could be the big year for the company. Its chief executive officer and president, Isaac Ciechanover, is leaving the company by June 30, but says 2019 could be transformative.

March 7, 2019
·
3 min read
·
Mark Terry
Business

Positive Readouts for Axsome and Galapagos Could Cause Stocks to Skyrocket, Analyst Predicts

In February, Galapagos NV Chief Executive Officer Onno van de Stolpe promised that 2019 will be a “data rich year” for the Belgium-based company and its lead product, filgotinib.

March 7, 2019
·
2 min read
·
Alex Keown
Job Trends

BioSpace Movers and Shakers: March 8

Perhaps the biggest mover and shaker announcement this week was the unexpected resignation of Scott Gottlieb, commissioner of the U.S. Food and Drug Administration. Gottlieb will leave his post later this month to spend more time with his family.

March 7, 2019
·
5 min read
·
Alex Keown
BioForest

Companies Focus on STING Pathway to Boost Immune Response in Patients

The drugs target a protein called STING (stimulator of interferon genes), which plays an important role in the innate immune system, which is the body’s first line of defense against various pathogens.

March 7, 2019
·
4 min read
·
Alex Keown
Policy

Sangui BioTech: Patent granted to Sangui for possible Septic Shock treatment

The European Patent Office has granted a patent for Sangui’s proposed technology/treatment (SBT 102) for septic shock patients, effective March, 6, 2019*.

March 7, 2019
·
2 min read
First-in-Human Results of SynGEM Demonstrate that the RSV Vaccine Is Well-Tolerated and Capable of Inducing Long-Lasting Immune Responses

SynGEM a needle-free nasal spray vaccine against respiratory syncytial virus

March 7, 2019
·
6 min read
Business

Who Will Replace Scott Gottlieb as Head of the FDA?

Gottlieb announced his intention to leave the FDA earlier this week. The Trump administration will have a list of candidates to choose from as it moves forward.

March 7, 2019
·
3 min read
·
Alex Keown